Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 06, 2024

SELL
$0.28 - $1.16 $32,763 - $135,732
-117,011 Reduced 38.39%
187,786 $61,000
Q1 2024

May 07, 2024

SELL
$1.06 - $1.67 $19,045 - $30,004
-17,967 Reduced 5.57%
304,797 $353,000
Q4 2023

Feb 09, 2024

BUY
$1.26 - $1.79 $161,200 - $229,007
127,937 Added 65.67%
322,764 $545,000
Q3 2023

Nov 03, 2023

BUY
$1.61 - $2.54 $5,834 - $9,204
3,624 Added 1.9%
194,827 $352,000
Q2 2023

Aug 09, 2023

SELL
$1.14 - $1.95 $108,431 - $185,474
-95,115 Reduced 33.22%
191,203 $355,000
Q1 2023

May 09, 2023

BUY
$1.2 - $2.19 $505 - $921
421 Added 0.15%
286,318 $380,000
Q4 2022

Feb 13, 2023

SELL
$1.63 - $3.52 $118,013 - $254,851
-72,401 Reduced 20.21%
285,897 $483,000
Q3 2022

Oct 27, 2022

SELL
$0.73 - $3.74 $69,238 - $354,727
-94,847 Reduced 20.93%
358,298 $1.12 Million
Q2 2022

Aug 01, 2022

BUY
$2.2 - $4.2 $448,175 - $855,607
203,716 Added 81.67%
453,145 $1.08 Million
Q1 2022

May 11, 2022

BUY
$2.83 - $8.69 $705,884 - $2.17 Million
249,429 New
249,429 $1.01 Million
Q4 2021

Feb 11, 2022

SELL
$8.31 - $14.92 $66,480 - $119,360
-8,000 Closed
0 $0
Q3 2021

Nov 10, 2021

BUY
$9.15 - $13.28 $73,200 - $106,240
8,000 New
8,000 $93,000

Others Institutions Holding DNA

About Ginkgo Bioworks Holdings, Inc.


  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $12.1B
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track This Portfolio

Track Us Bancorp \De\ Portfolio

Follow Us Bancorp \De\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.